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Abstract 
Background & Aims: Minimal hepatic encephalopathy (mHE) has been shown to affect daily 
functioning, quality of life, driving and overall mortality. However, little is known about treating 
or diagnosing early impairments in mHE. We studied one of its precipitating factors, portal 
hypertension. The purpose was to evaluate the presence of histological changes in the eye in 
mHE and whether these changes could be related to deficits in behavioral task acquisition. 
Methods: Rats were trained on a stimulus-response task and a spatial working memory task 
using the Morris water maze. Two groups of animals were used: a SHAM (sham-operated) group 
(n = 15) and a portal hypertension (HT) group (n = 15). The triple portal vein ligation method 
was used to create an animal model of mHE. Latencies to reach the platform, number of glial 
fibrillary acidic protein-immunoreactive astrocytes (GFAP-IR), mast cell expression and 
presence/absence of blood and lymphatic vessels were examined. Results: There were 
differences in stimulus-response behavioral performance, with a deficit in the acquisition in the 
HT group. However, no differences between groups were found on the spatial working memory 
task. At the same time, differences between groups were found in the GFAP-IR density, which 
was lower in the HT group, and in the number of mast cells and the presence of vessels, which 
were higher in the HT group. Conclusions: In this study, we provide the first preliminary insight 
into the validity of exploring the eye as a possible tool to assess the diagnosis of mHE 
conditions. 
Keywords: minimal hepatic encephalopathy; stimulus-response task; striatum; GFAP-IR; 
mast cells; LYVE-1; TNF-α; α-SMA. 
Key points: 
 Portal hypertension as precipitant factor of mHE was studied. 
 Behavioral deficits in stimulus-response task but not in working memory were found. 
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 Brain changes through GFAP-IR showed lower expression in HT group. 
 Mast cells and vessels in cornea were higher in HT group. 
 
1. INTRODUCTION 
 
Portal hypertension is a clinical syndrome defined by a pathological elevation of blood 
pressure in the portal system [1]. In humans, portal hypertension is characterized by prolonged 
elevation of portal venous pressure greater than 10 mmHg [2] which leads to hyper-dynamic 
circulation [3] and the creation of a portosystemic collateral circulation [4], due not only to the 
opening of preexisting vessels, but also to the formation of new vessels. 
Portal hypertension and excess ammonia due to liver failure seem to be the main 
contributing factors leading to different cerebral and neurological alterations and to the 
occurrence of hepatic encephalopathy (HE) [5]. However, the role of ammonium is still under 
debate. Shawcross et al. [6] showed that systemic inflammation exacerbated psychological 
impairment in hyperammonemic cirrhosis patients, and after treatment for this inflammatory 
response, this impairment was reversed, even in the presence of similar hyperammonemia [6]. 
This result suggests that the behavioral impairments often associated with the onset of 
hyperammonemia in liver disease may be reliant on the interaction of ammonia with other 
metabolic and systemic perturbations. Moreover, recent findings highlighted the absence of task 
performance impairments due to hyperammonemia, which questions the importance of ammonia 
alone in HE symptom development [7]. So, how can portal hypertension trigger HE? 
First, this increased blood flow is understood as stress stimuli by the vascular 
endothelium, producing an inflammatory response [8], which, by extension, affects the organs 
into which the blood drains. It has been shown that mast cells are the first responders to this 
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mechanical stimuli and are able to initiate inflammation due to their strategic location close to 
blood vessels [9] in the skin, airways and gut [10]. In fact, highlighting this function, mast cell 
infiltration has been found in great density in the duodenum, jejunum, ileum and superior 
mesenteric lymph node complex [11,12] in portal hypertensive rats at six weeks of evolution. 
Moreover, mast cells can migrate through intestinal lymph vessels to the systemic circulation and 
nervous system [13]. 
Regarding the nervous system, it has been shown that portal hypertensive-rats present 
increased SDF-1 alpha levels in the hippocampus and cerebellum, associated with increased 
TNF-α and CXCR4 levels in the hippocampus [14], which could be related to a structural 
remodeling process to adapt cerebral areas to the new metabolic state created by the portal 
hypertension [15]. Moreover, inflammation in the context of portal hypertension can arise 
directly in the brain, resulting in astrocytic, microglial and neuronal dysfunction, and taking part 
in the development of minimal hepatic encephalopathy (mHE) [16]. 
Second, the increase in the diameter and number of blood vessels in the submucosa has 
already been shown in the duodenum of portal hypertensive rats at six weeks of evolution. 
Furthermore, this process has been correlated with mast cell infiltration [11].  
Both blood and lymph cells penetrate most tissues in the body, and dysfunction in their 
circulation is involved in a broad spectrum of diseases [17]. The cornea is the most well-studied 
and well-characterized eye tissue in blood and lymphatic vessel research [18]. As the forefront 
medium in the passage of light to the retina, it maintains a natural transparency and is devoid of 
any vasculatures. In addition, light-microscopic evidence for the invasion of lymphatics into 
heavily vascularized rabbit corneas has been reported [19], and vessels with thickened basement 
 7 
membranes have also occurred in aging [20] and in various pathologic conditions [21,22], 
including diabetes mellitus [17]. 
In light of these data, the aims of this work were: (i) to reproduce the portal hypertension 
clinical symptoms that lead to the development of mHE; (ii) to highlight the existence of 
asymmetric cognitive differences in the mHE animals through the performance of a stimulus-
response task and a working memory task; (iii) to explore the existence of earlier and accessible 
biomarkers to determine the contribution of portal hypertension to the development of mHE 
through cornea exploration. 
 
2. MATERIAL AND METHODS 
 
2.1. Animals 
We used 30 male Wistar rats from the vivarium of the University of Oviedo, weighing 250-
270 g at the beginning of the study. Rats were housed in groups of three to five, three weeks 
prior to the beginning of the experiments and maintained under standard laboratory conditions 
(20-22 ºC, 65-70% relative humidity and a 12h light/dark cycle (08.00-20.00/20.00-08.00)). 
Food and water were available ad libitum throughout the course of all the experiments, and 
sessions were performed during the light phase, between 9:00 a.m. and 13:00 p.m. All 
procedures were carried out according to the European Parliament, Council of the European 
Union 2010/63/UE and ARRIVE guidelines. The protocol was approved by the Committee on 
the Ethics of Animal Experiments of the University of Oviedo (Permit Code: PSI2010-19348 
and PSI2013-45924-P); all efforts were made to minimize suffering. The animals were 
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distributed into portal hypertension and sham-operated animals (HT group, n = 15 and SHAM 
group, n = 15). 
 
2.2. Procurement of experimental models 
The experimental models that required surgery were anesthetized by i.p. injection of 
ketamine (100 mg/kg) and xylacine (12 mg/kg). With regard to postsurgical care, the rats were 
maintained close to a source of heat until they recovered consciousness (10 -15 min) to avoid 
postoperative hypothermia. They were then introduced into individual polycarbonate cages for 
15 days and subsequently grouped in cages of four animals each until their behavioral 
evaluation.  
 
2.2.1. Portal hypertension 
 A midline abdominal incision was performed, and a section of the intestinal loop was 
gently shifted to the left and covered with saline-moistened gauze. The portal vein was isolated, 
and three ligatures, fixed on a sylactic guide, were performed in its superior, middle and inferior 
portions. The stenoses were calibrated by simultaneous ligation (4-0 silk) around the portal vein 
and a 20-gauge blunt-tipped needle. The abdominal incision was closed in two layers with 2-0 
silk. The postoperative period started immediately after the intervention and lasted until the 
behavioral evaluation 45 days later. 
 
2.2.2. Sham-operated 
 A midline abdominal laparotomy with prolongation to the xyphoid apophysis was 
performed, followed by isolation of the portal vein. The operative field was irrigated with saline 
solution during the intervention, as in the portal hypertension interventions. Finally, the 
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laparotomy was closed by continuous suture on the two layers with 2-0 silk. The postoperative 
period started immediately after the intervention and lasted until the behavioral evaluation 45 
days later. 
 
2.3. Portal vein pressure measurement 
Splenic pulp pressure, an indirect measurement of portal pressure (PP), was measured using 
the method described by Aller et al. [23]. 
 
2.4. Stimulus-response “habit” task 
The water maze was made of fiberglass and measured 150 cm in diameter, with a 40 cm high 
wall. The water level was 30 cm, and its temperature was 22±2°C. The platform used 
corresponded to a cylinder that was 10 cm in diameter and 28 cm high, of which 2 cm was below 
the surface of the water. The water maze was in the center of a 16 m2 lit room (two halogen 
lamps of 4000 lx) and divided into four starting positions (north, south, east and west). A white 
plastic glass was attached to the top of the submerged platform and protruded above the water 
surface. The platform could be used as a step to mount the glass to escape the water. The 
behavior of the animal in the MWM was recorded by a video camera (Sony V88E) connected to 
a computer equipped with an EthoVision Pro program. 
After the postoperative period of 45 days, rats were trained in one session (which took an 
average of 10 min) using a pre-set criterion where sham-operated rats had to achieve two 
consecutive trials with retention latencies under 8 s, and it could take them no more than 10 trials 
to reach this criterion, as in previous studies [24]. Thus, to ensure that an animal had reached the 
behavioral criterion, the presence of two consecutive trials with retention latencies under 8 s 
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should be required. For each cued training trial, the animal was placed in the tank facing the wall 
at one of four designated starting points (N, S, E and W) and allowed to escape onto the visibly 
cued platform. The visible escape platform was located in a different quadrant in each trial. A 
different starting point was used in each trial. Each trial ended once the animal had found the 
platform, or when 60 s had elapsed. If the animal had not reached the hidden platform after this 
time, it was placed on the platform for 15 s. During the inter-trial interval, the animals were 
placed in a black bucket for 30 s. Latencies to reach the escape platform were recorded and used 
as a measure of task acquisition. 
 
2.5. Spatial working memory task 
The spatial working memory was evaluated in the MWM as described by Méndez-López et 
al., [25]. Briefly, a habituation session was performed one day prior to the training schedule. The 
WM training involved a paired sample task. Each daily session consisted of two identical trials 
(sample and retention). During both trials, the platform was hidden 2 cm below the level of the 
water. The sample consisted of releasing the animal from one of the four starting points in the 
pool and letting it swim until it reached the hidden platform or 60 sec had elapsed. If the animal 
had not reached the hidden platform in this time, it was placed on the platform and kept there for 
15 sec. The intertrial interval was 5 s. The task requires the animal to recall the position of the 
hidden platform during the sample. The locations of the platform and the starting positions 
varied on the different days in a pseudorandom order. Training finished when the group achieved 
the learning criteria, established as statistically significant lower retention latency compared to 
sample latency within one session, and also compared to the retention latency of the first session. 
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2.6. GFAP Immunohistochemistry 
Sections of five animals from the SHAM group and five from the PH group were used to 
quantify the density of GFAP-IR in the dorsal hippocampus, dorsal and ventral striatum. The rats 
were anesthetized with sodium pentobarbital (100 mg/Kg) (Sigma-Aldrich) and intracardially 
perfused with phosphate buffer saline at 0.9% (PBS) (0.1 M; pH 7.4), followed by 
paraformaldehyde at 4% in PBS (0.1 M; pH 7.4). The brains were extracted and introduced in 
paraffin. Systematic cuts were made on both regions with a microtome (Leica, Germany) in 30-
μm thick serial sections at a known interval from the beginning to the end. 
We performed GFAP-IR immunocytochemistry according to the method described by 
Blanco et al [26], which briefly consists of washing the previously deparaffinized sections in Tris 
Buffer saline (TBS) with Triton X-100 at 0.1%, and blocking them with human serum. 
Afterwards, these sections were incubated for one day with rabbit polyclonal primary antibody 
anti GFAP (1:800 in bovine albumin, BSA). The next day, after rinsing them in TBS with Triton 
X-100, we incubated them with a biotinylated secondary antibody (goat anti-rabbit IgG, 1:30 in 
BSA) and applied the avidin-biotin horseradish peroxidase complex (Vectastain Ultra-Sensitive 
ABC Staining Kit), developed with diaminobenzidine tetrahydrochloride, and cover-slipped the 
sections. 
The entire quantification process was carried out using a Leica LAS Live Image Builder 
(Leica, Microsystems). To estimate the density of GFAP-IR, we used at least three equidistant 
sections in the selected structures from each animal. Quantification was done by placing four 
equidistant counting frames (frame size 0.150 mm × 0.150 mm) on the screen. Only the cell 
bodies within each quadrant or dissector selected in the section were quantified. The total 
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thickness measured on each slide was 30 μm, leaving out 5 μm of thickness above and below the 
Z-axis to avoid possible overestimations. 
2.7. Mast cells and vessels techniques 
 
2.7.1 Macroscopic evaluation of the ocular surface 
Rats’ ocular surface was examined macroscopically under a Leica S6D stereoscopic 
microscope equipped with a Leica EC3 digital camera (Leica Microsystems,Wetzlar, Germany) 
to register the presence of blood and lymphatic vessels and leucomas in the cornea of the eye. 
Images were taken under a fixed 12.5X magnification. 
Blood and lymphatic vessels were first registered as present or not present (assigned 1 
and 0 values, respectively) in macroscopic images of the ocular surface of portal hypertension 
and sham-operated rats. The presence of lymphatic vessels in the corneal tissue was assessed by 
studying the LYVE1 immunohistochemical slides. Samples with LYVE1 positive vessels were 
registered as 1, and negative samples were assigned a 0 value. 
 
2.7.2 Tissue Preparation 
Once the behavioral studies and macroscopical examination were finished, animals were 
killed by decapitation, and their eye globes were enucleated and immersed in 4% 
paraformaldehyde fixative for 2 hours. Samples were then cryoprotected in 30% buffered 
sucrose solution, embedded in OCT compound (Sakura Finetek, Torrance, CA) and snap frozen 
in liquid Nitrogen. Serial 5 µm thick transverse sections containing the cornea and conjunctiva of 
the eye were obtained on a Microm HM 550 cryostat (Microm International GmbH, Walldorf, 
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Germany) and collected on microscope slides (Superfrost Plus, Menzel-Gläser GmbH, 
Braunschweig, Germany). 
 
2.7.3 Immunocytochemistry 
For fluorescent immunocytochemical preparations (both flat mounts and cryosections), 
the samples were blocked at room temperature (RT) with 10% goat normal serum and 1% of 
bovine serum albumin in phosphate buffer saline (PBS) 0.1 M pH 7.4 for two hours and 
incubated overnight with rabbit polyclonal antibodies to LYVE1 and TNF-α or mouse 
monoclonal antibody to α-SMA (α-smooth muscle actin) (all from Abcam, Cambridge UK). 
After washing three times in PBS, samples were incubated for 2 hours at RT with the 
corresponding secondary antibody (anti-rabbit IgG Alexa Fluor 488 or anti-mouse IgG Alexa 
Fluor 594, from Molecular Probes), rinsed again in PBS, and incubated for 10 minutes in 4’,6-
diamidino-2-phenylindole (0.2µg/mL DAPI). Finally, the tissue sections were washed in PBS 
and mounted in DAKO fluorescence mounting medium (DAKO). 
To study the coexistence of lymphatic vessels and mastocytes in the same samples, 
immunohystochemical techniques were performed. After blocking endogenous peroxidase 
activity (3% H2O2 in methanol for 5 min), tissue sections were placed in a humidity chamber, 
blocked at room temperature (RT) with 10% goat normal serum for 2 hours, and incubated 
overnight in 10 µg/mL anti-LYVE1 primary antibody (rabbit polyclonal to LYVE1-Lymphatic 
vessel marker; Abcam, Cambridge, UK). After washing three times in PBS, the sections were 
incubated for 2 hours at RT in the secondary antibody (biotinylated goat anti-rabbit IgG, 1:200; 
Vector Laboratories, Burlingame, CA), rinsed again in PBS, and incubated for 2 hours at RT in 
avidin-biotin-horseradish peroxidase complex (ABC reagent kit; Vector Laboratories). Then the 
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tissues were incubated for 5 min at RT in 0.02% diaminobenzidine (Sigma-Aldrich, St. Louis, 
MO, USA) and 0.003% H202, and then rinsed three times in PBS and twice in distilled water. 
Sections were then counterstained with toluidine blue. 
2.7.4 Mast cell staining 
To stain mast cells present in the connective tissue, sections previously immunostained to 
LYVE1 were counterstained with 0.1% toluidine blue (Sigma-Aldrich) in 1% NaCl for 2 min at 
RT, washed three times in distilled water, dehydrated in graded alcohols, cleared in xylene, and 
cover-slipped with Entellan (Merck, Darmstadt, Germany). 
All images were obtained using a Leica DM 6000B microscope equipped with a Leica 
DFC310 FX camera (Leica Microsystems) and using a partial Nomarski illumination method. To 
quantify the number of mast cells present in the conjunctiva surrounding the cornea in portal 
hypertension and sham-operated animals, 3 histological sections through the central region of the 
cornea of each eye globe were used. Sections were spaced 50 µm from each other. Mast cells 
were counted manually in the conjunctiva on both sides of the cornea in the histological 
preparation. Only cells contained in a 40X magnification objective field (under a Leica DM 
6000B microscope), starting at the corneoscleral limbus, were considered.  
 
2.8. Statistical analysis 
All data were analyzed in the Sigma-Stat 3.2 program (Systat, Richmond, USA) and 
expressed as the mean ± SEM. The results are considered statistically significant if p < 0.05. 
A t-test for independent samples was used for the statistical comparison of portal 
pressures, mast cell expression and vessel presence. The latencies to reach the visibly cued 
platform during the training phase of the stimulus-response “habit” task were analyzed with a t-
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test for independent samples. Moreover, a comparison between trial-performance in each group 
was analyzed by one-way repeated-measures ANOVA. Post hoc multiple comparison analyses 
were carried out when allowed, using pair-wise Tukey tests. Moreover, a non-parametric Mann–
Whitney U test (U) for independent samples was conducted when normality or equal group 
variances failed. 
A one-way ANOVA was used to compare distance covered and velocity between groups 
in the sample and retention trials during spatial working memory performance. Furthermore, a 
comparison of latencies between trial-performance in each group during sample and retention 
trials was analyzed by two-way repeated-measures ANOVA. 
A t-test was used to analyze differences in GFAP-IR, mast cells, lymphatic and blood 
vessels between portal hypertension and sham-operated animals. Moreover, a non-parametric 
Mann–Whitney U test (U) for independent samples was carried out when normality or equal 
group variances failed. 
3. RESULTS 
 
3.1. Portal Pressure 
Portal pressure increased in all the animals with portal hypertension (15.998±0.663) (U = 
55.000, n1 = 10, n2 = 10, P < 0.001), compared to that of the sham-operated animals 
(6.705±0.267). This piece of data is important because it ensures the presence of portal 
hypertension in the HT group, which could explain differences in learning and the early 
development of mHE in the model. 
 
3.2. Stimulus-response “habit” task 
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The t-test for independent samples showed differences in escape latencies between the HT 
and SHAM groups (t8 = -2.328, P = 0.048), revealing the inability of HT animals to reach the 
behavioral criterion compared to the SHAM group. When a one-way repeated-measures 
ANOVA was carried out in both groups, the HT group did not show differences in their escape 
latencies across trials (F(4,36) = 1.000, P = 0.458). However, there was a significant effect of the 
variable trial (F(4,36) = 3.747, P = 0.002) in the SHAM group, with a progressive latency 
reduction being found across trials 7 (P = 0.029), 9 (P = 0.003) and 10 (P = 0.003), compared to 
trial one (Figure 1). 
 
3.3. Spatial working memory task 
The one-way ANOVA revealed no differences between the HT and SHAM groups in distance 
covered during the sample (F(1,9) = 0.534, P = 0.486) and retention phases (F(1,9) = 0.235, P = 
0.641). In addition, no differences were found in velocity during the sample (F(1,9) = 0.305, P = 
0.596) and retention (F(1,9) = 0.924, P = 0.365). Finally, the two-way repeated-measures ANOVA 
showed no differences in latencies during the sample between groups (F(1,59) = 1.189, P = 0.307) 
or between days (F(5,59) = 0.92, P = 0.483), and no interactions between group and day were 
found (F(5,59) = 0.429, P = 0.826). Moreover, no differences in latencies during retention were 
found, respectively (F(1,59) = 0.137, P = 0.721; F(5,59) = 0.441, P = 0.817; F(5,59) = 2.469, P = 0.05; 
Figure 2). 
3.4. GFAP-IR results 
GFAP represents the most specific astrocytic marker under normal and pathological 
conditions [27]. Differences in the GFAP-IR astrocyte number were found between groups in 
ADS (t8 = 4.765, P = 0.001) and AMS (t8 = 5.317, P < 0.001), where the number was 
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significantly lower in the HT group than in the SHAM group. However, no differences were 
found in ALS (t8 = 2.138, P = 0.065), ACC (U = 19.000, n1 = 5, n2 = 5, P = 0.095), ACS (U = 
28.000, n1 = 5, n2 = 5, P = 1.000), CA1 (t6 = 0.302, P = 0.773), CA3 (t6= 0.424, P = 0.687) or 
DG (t6 = 0.0989, P = 0.924). (Figure 3). Our results showed a decrease in GFAP-
immunoreactive astrocytes in the striatum in early stages of HE. 
 
3.5. Macroscopic assessment of the ocular surface 
The ocular surface revealed differences between the SHAM and HT groups, where no 
pathological signs were found in the SHAM group, whereas the HT group showed the presence 
of whorls of blood vessels and leucomas (Figure 4). 
 
3.6. Mast cell results 
Differences were found between the HT and SHAM groups in the RE (t8 = 3.036, P = 0.016) 
and in the LE (t8 = 4.000, P = 0.004). However, no differences in the number of mast cells were 
found between the eyes in each group: HT (t8 = 0.000, P = 1.000) and SHAM (t8 = 0.431, P = 
0.678; Figures 5). 
 
3.7. Lymphatic and Blood vessel results 
Differences were found in the HT and SHAM groups for both types of vessels, with the HT 
group showing a greater presence of these vessels in both eyes (U = 37.500, n1 = 5, n2 = 5, P = 
0.032). Otherwise, no differences were found between RE and LE in each group: HT (U = 
30.000, n1 = 5, n2
 = 5, P = 0.690) and SHAM (U = 27.500, n1 = 5, n2 = 5, P = 1.000; Figures 5 
and 6). We found lymphatic vessels in every cornea containing blood vessels. 
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Moreover, an additional staining of blood vessels and lymphatic vessels was done to 
support our data (Figure 7 A and B). Finally, the occurrence of lymphatic vessels in corneas 
from the HT group was accompanied by the expression of TNF-α in cornea (Figure 7 C and D). 
The TNF-α was highly expressed in the epithelium in terms of immunofluorescence intensity, 
compared to SHAM rats. In addition, we observed TNF-α positive elements in the upper stroma 
and profiling vessels coinciding with LYVE1 positive vessels (Figure 7 D and F). 
 
4. DISCUSSION 
 
 Our work revealed that one of the main contributing factors to HE, portal hypertension, 
reproduced by a model of triple portal vein ligation [28], was related to cognitive deficits due to 
the development of mHE, detected early due to the presence of histological changes in the 
cornea. 
 When one of the main contributing factors to HE, portal hypertension, is reproduced by a 
model of triple portal vein ligation [5], differences in portal pressure values between the HT and 
SHAM groups are found, confirming the great development of the model. Moreover, the inability 
of HT animals to reach the behavioral criterion, compared to the SHAM group, during their 
performance of a stimulus-response task in which the visible platform was pseudo-randomly 
repositioned across trials to render its relation with distal cues trivial [28], highlighted the 
existence of a cognitive impairment in early stages of the disorder, referred to as minimal hepatic 
encephalopathy (mHE). 
 It is well known that at chronic stages of the HE disorder (bile duct ligation model) 
alterations in motor activity and mnemonic functions along with decreases in dopamine and 
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serotonin levels in the cortex, hippocampus, striatum and cerebellum have been reported [29]. 
However, in this study we are evaluating a model of one of the precipitating factors of minimal 
hepatic encephalopathy in the early stages of the disorder’s development. Under these conditions, 
previous studies in our group have reported no motor alterations, slight deficits in spatial learning 
tasks [30], and different alterations in several brain regions on object-place recognition and 
reversal tasks [31].  
Based on these previous results, we decided to explore the possibility of early 
impairments in the hippocampal system and striatum through the performance on two different 
behavioral tasks guided by a double dissociation between them, with the acquisition of the visible 
platform task being more striatum-dependent [32] and the spatial working memory task being 
more hippocampal-dependent [25]. Our results could suggest impairment in the striatum as one 
of the first targets in early stages of HE, due to the inability of these animals to perform the 
stimulus-response task, but no hippocampal damage, due to the lack of differences in the 
performance on the spatial working memory task, highlighting an asymmetric deficit at early 
stages of HE. 
 This asymmetry in the performance of both tasks could be related to a differential damage 
at early stages of HE. Arias et al. [33] have suggested the striatum as the brain structure primarily 
affected by inflammatory factors such as TNF-α highlighting the inflammatory origin of this 
disorder. Based on these data and taking into account that pro-inflammatory mediators (TNF-α) 
even lead to decreased GFAP expression [37], we attempted to assess glial damage through the 
study of GFAP-IR density in the dorsal hippocampus and striatum. 
We found decreased GFAP-IR in the dorsal striatum in the HT group compared to the 
SHAM group, while no changes were found in the hippocampus. GFAP represents the most 
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specific astrocytic marker under normal and pathological conditions [27], and GFAP-
immunoreactive astrocytes were found to be decreased in number in the cerebral cortex of rats 
with chronic liver failure resulting from portocaval anastomosis [34]. Similarly, decreased 
GFAP-IR was reported in human chronic liver failure in the basal ganglia, cerebral cortex and 
thalamic structures [35]. These results could support the inability of HT animals to perform the 
stimulus-response task compared to the working memory task. But, how could we asses to this 
brain damage at clinical level? 
A growing evidence supporting the role of inflammation in exacerbating the neurological 
manifestations in HE has been shown. Previous studies have reported that inflammation is 
perhaps the fundamental factor in which more metabolic alterations progressively develop [36], 
however, little is known about the evolution of lymphatic vessels along the development of this 
disorder.  
 It is widely accepted that blood and lymph cells penetrate most tissues in the body, and a 
dysfunction in their circulation is involved in a broad spectrum of diseases. In fact, angiogenesis 
and lymphangiogenesis, the formation of new blood and lymphatic vessels, are important aspects 
of tumor growth and inflammatory diseases [37]. However, unlike blood vessels, lymphatic 
vessels were not easily visible until the lymphatic vessel endothelial hyaluronic acid receptor-1 
(LYVE-1) was identified [38].  
 In recent years, it has become clear that lymphangiogenesis can occur along with 
hemangiogenesis [39]. The cornea has been shown to be a great place to examine the formation 
of these new vessels because a normal human cornea has no blood or lymphatic vessels, but 
secondary to a disease, the cornea can become vascularized, a phenomenon that has been 
described both clinically and histopathologically [40]. It is known that vascularization in the 
cornea disturbs visual acuity, whereas corneal lymphangiogenesis modulates corneal immunity or 
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inflammation. However, in both cases, cornea neovascularization represents a major public health 
burden, almost always impairing visual function and sometimes ultimately leading to blindness. 
But what is the basis for these processes? 
As we mentioned above, a normal cornea is avascular [45]; however, under certain 
conditions, such as inflammatory disorders or portal hypertensive encephalopathy, capillaries 
invade from the limbal vascular plexus, causing corneal neovascularization, as our results 
showed. As a consequence of an inflammatory process, the expression of chemokines and 
adhesion molecules is implied [46]. In fact, our results revealed that TNF-alpha is highly 
expressed in the HT group cornea compared to the SHAM group. These factors initiate the 
recruitment of inflammatory cells in the conjunctival mucosa where the mast cells are. Activated 
mast cells can release several citokines, such as VEGF A, which plays a crucial role in inducing 
inflammatory neovascularization by supplying signals essential for pathological hemangiogenesis 
and lymphangiogenesis [47], and VEFG C and D, which are required for lymphangiogenesis 
[37,48].  
Moreover, the appearance of an increased number of activated mast cells in HT group 
compared to SHAM group could be showing a bidirectional crosstalk between mucosal mast 
cells, the enteric system and brain [44], and it suggest that these inflammatory cells are potential 
integrators of the systemic inflammatory response that induces portal hypertension, leading to 
mHE. 
 Our study provides the first analysis of the pathologic distributions of blood and 
lymphatic vessels, as well as the presence of pro-inflammatory factors, such as TNF-alpha in the 
cornea and striatal decreased in GFAP-IR, along with cognitive deficits at early stages of HE 
trigger by the development of portal hypertension. These results reveal that the cornea is an 
important tool for the early diagnosis of portal hypertension’s contribution to the development of 
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mHE. Finally, we presented behavioral and histological results that provide fresh insights into the 
development of new tools for the assessment of portal hypertension as a marker of mHE. Our 
research opens a new door to future tools for the early diagnosis of dysfunction in patients with 
mHE. 
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Figure Captions 
Figure 1. Latencies to reach the platform were calculated. Differences in escape latencies 
between the HT and SHAM groups were shown. * represents shorter latencies during trials 7, 9 
and 10 compared to trial 1 (P < 0.05). Data represent mean±SEM. 
Figure 2. Latencies to reach the platform during sample and retention in the spatial working 
memory test. No differences were found between groups. Data represent mean±SEM. 
Figure 3. GFAP immunoreactivity results. Differences in the astrocyte number were found 
between groups in ADS and AMS. Data represent mean±SEM. 
Figure 4. Macroscopic aspect of the ocular surface of the sham-operated group (A) and portal 
hypertension group (B and C). There were no pathological signs in the sham-operated cornea 
group (A). Vessels from the iris can be observed by transparency. In image B, whorls of blood 
vessels are present in the central cornea (arrowheads). Some white deposits (asterisk; leucomas) 
could be seen in the vicinity of vessels. In image C, dense corneal leucomas (asterisks) could be 
seen, associated with blood vessels (arrowheads). (Scale bars 50 µm). 
Figure 5. A. Number of mast cells (mean±SEM) in the HT and SHAM groups. # P < 0.05 was 
significantly higher in the HT group compared to the SHAM group. B. Represents the absence or 
presence of blood and lymphatic vessels (mean±SEM) in the HT and SHAM groups. # P < 0.05 
was significantly higher in the HT group compared to the SHAM group. 
Figure 6. Corneas from sham-operated animals showed a normal epithelial and stromal 
morphology (A). In B, mast cells (arrows) were found in low numbers in the vicinity of blood 
(asterisks) and LYVE1 positive lymphatic vessels (arrowheads) in sham-operated animals. A 
majority of the portal hypertensive rats presented large blood and LYVE1 positive lymphatic 
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vessels (arrowheads) invading the corneal tissue (C). Epithelial morphology was also altered. 
Hypertensive animals presented a significantly higher number of mast cells in the conjunctiva 
(D). (Scale bars 25 µm). 
Figure 7. Immunofluorescent assay to demonstrate lymphatic vessels in cornea and TNF-α 
inflammatory marker. Coexistence of LYVE1 positive lymphatic vessels (arrowheads) and α-
SMA positive blood vessels (asterisks) in the same region of the cornea in a flat mounted 
preparation of a hypertensive rat (B) Epithelium presented severe alterations in vascularized 
regions. Sham group corneas showed no alterations in their surface (A). In transversal sections, 
LYVE1 is overexpressed in the HT group in the epithelium and surrounding a lymphatic vessel 
(D). SHAM corneas showed a faint staining for LYVE1 in the epithelium (C). In a consecutive 
section from the same sample (F), we can observe the presence of TNF-α in the same vessel 
demonstrated previously with LYVE1 (D). TNF-α fluorescence is increased in the epithelium 
and upper stroma in HT corneas (F) compared to the sham group, where no expression of TNF-α 
is visible (E). (Scale bars 50 µm in A and B; 20 µm in C - F).  
 
